Sanofi reports positive top-line results from first Phase 3 Study of Alemtuzumab (Lemtrada™)
Sanofi and Genzyme announced positive top-line results...
11 July 2011 | By Sanofi
Sanofi and Genzyme announced positive top-line results...
List view / Grid view
Sanofi and Genzyme announced positive top-line results...
11 July 2011 | By Sanofi
Sanofi and Genzyme announced positive top-line results...
Sanofi announced the strategic divestiture of its dermatology business, Dermik,…
11 July 2011 | By Sanofi
Sanofi announced the strategic divestiture of its dermatology business, Dermik, to Valeant Pharmaceuticals International Inc...
Sanofi-aventis announced the signing of a cooperation agreement between Fovea…
23 March 2011 | By Sanofi-aventis
Sanofi-aventis announced the signing of a cooperation agreement between Fovea Pharmaceuticals & the Vision Institute...
Sanofi-aventis is pleased to announce the appointment of Dr. Richard…
11 March 2011 | By Sanofi-aventis
Sanofi-aventis is pleased to announce the appointment of Dr. Richard Klausner to Chairman of the SDSAC, effective March 1...